Ahmedabad-based Cadila Pharmaceuticals recently launched its Active Pharmaceutical Ingredients (API) Plant at Dahej in the Bharuch district.

The facility, which cost Rs 200 crore to build and is furnished with the newest automation technology for the Distributed Control System (DCS), represents a major advancement in Cadila Pharmaceuticals' commitment to quality and innovation in medication production.

Dr H. G. Koshia, Food Drug Commissioner for Gujarat, and Dr M. P. Nakarani, Assistant Commissioner of FDCA, Baruch Circle, were present on the occasion.

Speaking on the occasion, Biswajit Mitra, Chief Mentoring Officer at Cadila Pharmaceuticals and Convener Pharma Panel, CII Gujarat State, said, “The DCS technology used in this facility will allow us to produce APIs with a high level of purity and consistency, while also reducing the environmental impact. The implementation of the plant project will further extend our impact by generating employment opportunities for both permanent and contractual positions, thereby continuing our dedication to creating positive social change. ”

Cadila Pharmaceuticals had earlier signed an MoU with the government of Gujarat for investing Rs 1,000 crore in Gujarat. The Dahej API facility is one of the projects for which the MoU was signed.